Pregnancy exposure to midostaurin in the first trimester

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of hematology 2020-02, Vol.99 (2), p.355-356
Hauptverfasser:	Ojha, Soumya, Ooi, Melissa G
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cesarean Section Compassionate Use Trials Cytarabine - administration & dosage Female Fetal Growth Retardation - chemically induced Fetal Growth Retardation - etiology fms-Like Tyrosine Kinase 3 - antagonists & inhibitors fms-Like Tyrosine Kinase 3 - genetics Hematology Humans Infant, Newborn Infant, Premature Infant, Premature, Diseases - chemically induced Infant, Premature, Diseases - etiology Letter to the Editor Leukemia, Myeloid, Acute - drug therapy Leukemia, Myeloid, Acute - genetics Leukemia, Myeloid, Acute - physiopathology Medicine Medicine & Public Health Mutation Oncology Pregnancy Pregnancy Complications, Neoplastic - drug therapy Pregnancy Complications, Neoplastic - genetics Pregnancy Outcome Pregnancy Trimester, First - drug effects Protein Kinase Inhibitors - administration & dosage Protein Kinase Inhibitors - adverse effects Protein Kinase Inhibitors - pharmacology Recurrence Staurosporine - administration & dosage Staurosporine - adverse effects Staurosporine - analogs & derivatives Staurosporine - pharmacology Tandem Repeat Sequences
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!